Power Law company profile

MicroPort CardioFlow

Health Tech & Medtech · China · Founded 2015 · IPO 2021 Colt

Leading medical device company focusing on the development and commercialization of innovative and potentially optimal overall solutions in the field of heart valve diseases (subsidiary of MicroPort)

Valuation

$377M

Market cap · May/2026

Revenue

$50M

Latest reported FY

EBITDA

$5.6M

Latest reported FY

Featured in $1B+ revenueColt · Power Law growth-stage

Investors

6 investors on MicroPort CardioFlow's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 6 investors entered at this stage

GIC

Lake Bleu Capital

China Structural Reform Fund

3H Health Investment

CITIC Capital

Hillhouse Capital

Global footprint

Where MicroPort CardioFlow has talent and traffic

Workforce by country

🇨🇳 China HQ

Book a demo for the full country breakdown

Web traffic by country

580 monthly visits
across markets

🇭🇰 Hong Kong69%

🇺🇸 United States34.5%

Top 2 markets shown

Market sentiment

What the market is saying about MicroPort CardioFlow

An AI-synthesized read of the highest-engagement posts about MicroPort CardioFlow on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MicroPort CardioFlow on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles